Painful Peripheral Neuropathy and Cancer

Peripheral neuropathy (PN) is very prevalent in cancer patients and a leading cause of pain related to cancer. However, the underlying pathophysiological mechanisms vary significantly. Peripheral neuropathy can be a direct or an indirect complication of cancer or cancer-related treatment, or a pre-e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zis, Panagiotis, Varrassi, Giustino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693808/
https://www.ncbi.nlm.nih.gov/pubmed/28669084
http://dx.doi.org/10.1007/s40122-017-0077-2
_version_ 1783279988413300736
author Zis, Panagiotis
Varrassi, Giustino
author_facet Zis, Panagiotis
Varrassi, Giustino
author_sort Zis, Panagiotis
collection PubMed
description Peripheral neuropathy (PN) is very prevalent in cancer patients and a leading cause of pain related to cancer. However, the underlying pathophysiological mechanisms vary significantly. Peripheral neuropathy can be a direct or an indirect complication of cancer or cancer-related treatment, or a pre-existing comorbidity not related to cancer. PN might also occur as a paraneoplastic neurological syndrome. Such syndromes are immune-mediated manifestations that usually precede the diagnosis of cancer or cancer’s relapse. Pain is very prevalent in paraneoplastic peripheral neuropathies and, therefore, merits attention.
format Online
Article
Text
id pubmed-5693808
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-56938082017-11-30 Painful Peripheral Neuropathy and Cancer Zis, Panagiotis Varrassi, Giustino Pain Ther Editorial Peripheral neuropathy (PN) is very prevalent in cancer patients and a leading cause of pain related to cancer. However, the underlying pathophysiological mechanisms vary significantly. Peripheral neuropathy can be a direct or an indirect complication of cancer or cancer-related treatment, or a pre-existing comorbidity not related to cancer. PN might also occur as a paraneoplastic neurological syndrome. Such syndromes are immune-mediated manifestations that usually precede the diagnosis of cancer or cancer’s relapse. Pain is very prevalent in paraneoplastic peripheral neuropathies and, therefore, merits attention. Springer Healthcare 2017-07-01 2017-12 /pmc/articles/PMC5693808/ /pubmed/28669084 http://dx.doi.org/10.1007/s40122-017-0077-2 Text en © The Author(s) 2017 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Editorial
Zis, Panagiotis
Varrassi, Giustino
Painful Peripheral Neuropathy and Cancer
title Painful Peripheral Neuropathy and Cancer
title_full Painful Peripheral Neuropathy and Cancer
title_fullStr Painful Peripheral Neuropathy and Cancer
title_full_unstemmed Painful Peripheral Neuropathy and Cancer
title_short Painful Peripheral Neuropathy and Cancer
title_sort painful peripheral neuropathy and cancer
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693808/
https://www.ncbi.nlm.nih.gov/pubmed/28669084
http://dx.doi.org/10.1007/s40122-017-0077-2
work_keys_str_mv AT zispanagiotis painfulperipheralneuropathyandcancer
AT varrassigiustino painfulperipheralneuropathyandcancer

Ejemplares similares